CMTM3 and bladder transitional cell carcinoma: The univariate Cox regression analysis on OS showed that CMTM3 was a protective factor for ESCC, CHOL, KICH, and PRAD patients, while being a risk factor for BLCA, LUAD, COADREAD, COAD, OV, ACC, CESC, DLBC, KIRC, ESCA, KIRP, LIHC, LGG, MESO, PCPG, PAAD, READ, SARC, TGCT, STAD, THCA, UVM, GBMLGG, and ESAD patients.